Skip to main content
. 2018 Jul 5;13(7):e0199414. doi: 10.1371/journal.pone.0199414

Fig 2. Artificial antigen presenting cells (aAPCs).

Fig 2

(A)aAPC based on the K562 cell line encoding a non-signaling EGFRvIII mutant. (B)aAPC based on the K562 cell line encoding a non-signaling EGFRvIII mutant in addition to CD32, CD80, and CD137L. (C)G1-EGFRvIII CAR (D)G3-EGFRvIII CAR (E)Overall transduction and stimulation protocol for (F)three week and (G)six week (under selection) of CAR T-cells.